NCT02550288View on ClinicalTrials.gov

A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)

PHASE3CompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

September 29, 2015

Primary Completion Date

May 30, 2016

Study Completion Date

May 30, 2016

Conditions
Hypercholesterolemia
Interventions
DRUG

Ezetimibe 10 mg

DRUG

Atorvastatin 10 mg

DRUG

Placebo for Ezetimibe 10 mg tablet

DRUG

Placebo for Atorvastatin 10 mg capsule

BEHAVIORAL

Diet control/Daily Exercise

Diet and Daily exercise program as per Japan Atherosclerosis Society Guideline 2012 (JAS2012)

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT02550288 - A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383) | Biotech Hunter | Biotech Hunter